🔎 Trials Near Me

Home › Diffuse Large B-Cell Lymphoma › Oklahoma › Oklahoma City

Pag-aaral pangklinika para sa Diffuse Large B-Cell Lymphoma sa Oklahoma City, OK

Isang pag-aaral para sa Diffuse Large B-Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Oklahoma City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

Nagre-recruitPhase 2
  • University of Oklahoma Health Sciences Center, Oklahoma City
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT05890352

Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Nagre-recruitPhase 1
  • University of Oklahoma Health Sciences Center, Oklahoma City
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06015880

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Nagre-recruitPhase 2
  • University of Oklahoma Health Sciences Center, Oklahoma City
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT05633615

Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma

Nagre-recruitPhase 1/2
  • University of Oklahoma, Oklahoma City
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Mar 10, 2026 · NCT05256641

A Study of NX-1607 in Adults With Advanced Malignancies

Nagre-recruitPhase 1
  • University of Oklahoma, Oklahoma City
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2025 · NCT05107674

Pag-aaral para sa Diffuse Large B-Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Oklahoma City

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.